If you want more information about the SUROVA trial, you can visit our website.
Released January 2025
This tool helps estimate the risk of relapse or progression and mortality in advanced ovarian cancer patients (IIIB-IVB) based on clinical factors. The risk score calculation uses the beta coefficients of the dichotomized independent variables specified below, derived from a Logistic regression model built with the non-asian patients with high-grade ovarian cancer of the SUROVA dataset (N=2342, patients operated between January 1, 2018, and December 31, 2019). Enter the values below to calculate the patient's risk of death after treatment with a median follow-up of 43 months (range:0-80 months). 1100 patients had a follow-up of more than 55 months.